These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 32901119)
1. Novel antimicrobial development using genome-scale metabolic model of Gram-negative pathogens: a review. Chung WY; Zhu Y; Mahamad Maifiah MH; Shivashekaregowda NKH; Wong EH; Abdul Rahim N J Antibiot (Tokyo); 2021 Feb; 74(2):95-104. PubMed ID: 32901119 [TBL] [Abstract][Full Text] [Related]
2. Mastering the Gram-negative bacterial barrier - Chemical approaches to increase bacterial bioavailability of antibiotics. Ropponen HK; Richter R; Hirsch AKH; Lehr CM Adv Drug Deliv Rev; 2021 May; 172():339-360. PubMed ID: 33705882 [TBL] [Abstract][Full Text] [Related]
3. Rapid molecular tests for detection of antimicrobial resistance determinants in Gram-negative organisms from positive blood cultures: a systematic review and meta-analysis. De Angelis G; Grossi A; Menchinelli G; Boccia S; Sanguinetti M; Posteraro B Clin Microbiol Infect; 2020 Mar; 26(3):271-280. PubMed ID: 31751768 [TBL] [Abstract][Full Text] [Related]
4. A metabolic network approach for the identification and prioritization of antimicrobial drug targets. Chavali AK; D'Auria KM; Hewlett EL; Pearson RD; Papin JA Trends Microbiol; 2012 Mar; 20(3):113-23. PubMed ID: 22300758 [TBL] [Abstract][Full Text] [Related]
5. Multidrug-resistant gram-negative organisms: a review of recently approved antibiotics and novel pipeline agents. Provenzani A; Hospodar AR; Meyer AL; Leonardi Vinci D; Hwang EY; Butrus CM; Polidori P Int J Clin Pharm; 2020 Aug; 42(4):1016-1025. PubMed ID: 32638294 [TBL] [Abstract][Full Text] [Related]
6. New trends in pharmacogenomic strategies against resistance development in microbial infections. Ohlsen K; Dandekar G; Schwarz R; Dandekar T Pharmacogenomics; 2008 Nov; 9(11):1711-23. PubMed ID: 19018725 [TBL] [Abstract][Full Text] [Related]
7. Drivers of virulence and antimicrobial resistance in Gram-negative bacteria in different settings: A genomic perspective. Singh A; Rani PS; Bandsode V; Nyambero M; Qumar S; Ahmed N Infect Genet Evol; 2024 Oct; 124():105666. PubMed ID: 39242067 [TBL] [Abstract][Full Text] [Related]
8. Antibiotic adjuvants: an alternative approach to overcome multi-drug resistant Gram-negative bacteria. Liu Y; Li R; Xiao X; Wang Z Crit Rev Microbiol; 2019 May; 45(3):301-314. PubMed ID: 30985240 [TBL] [Abstract][Full Text] [Related]
9. Extensively drug-resistant and pandrug-resistant Gram-negative bacteria in a tertiary-care hospital in Eastern India: A 4-year retrospective study. Mohapatra DP; Debata NK; Singh SK J Glob Antimicrob Resist; 2018 Dec; 15():246-249. PubMed ID: 30144638 [TBL] [Abstract][Full Text] [Related]
10. Stress responses as determinants of antimicrobial resistance in Gram-negative bacteria. Poole K Trends Microbiol; 2012 May; 20(5):227-34. PubMed ID: 22424589 [TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of multidrug-resistant Gram-negative pathogens in three tertiary hospitals in Cairo, Egypt. El-Kholy AA; Girgis SA; Shetta MAF; Abdel-Hamid DH; Elmanakhly AR Eur J Clin Microbiol Infect Dis; 2020 May; 39(5):987-992. PubMed ID: 31953591 [TBL] [Abstract][Full Text] [Related]
12. Curative Treatment of Severe Gram-Negative Bacterial Infections by a New Class of Antibiotics Targeting LpxC. Lemaître N; Liang X; Najeeb J; Lee CJ; Titecat M; Leteurtre E; Simonet M; Toone EJ; Zhou P; Sebbane F mBio; 2017 Jul; 8(4):. PubMed ID: 28743813 [TBL] [Abstract][Full Text] [Related]
13. Genome-scale metabolic models as platforms for identification of novel genes as antimicrobial drug targets. Mienda BS; Salihu R; Adamu A; Idris S Future Microbiol; 2018 Mar; 13():455-467. PubMed ID: 29469596 [TBL] [Abstract][Full Text] [Related]
14. Infections by multidrug-resistant Gram-negative Bacteria: What's new in our arsenal and what's in the pipeline? Koulenti D; Song A; Ellingboe A; Abdul-Aziz MH; Harris P; Gavey E; Lipman J Int J Antimicrob Agents; 2019 Mar; 53(3):211-224. PubMed ID: 30394301 [TBL] [Abstract][Full Text] [Related]
15. Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens? Domalaon R; Idowu T; Zhanel GG; Schweizer F Clin Microbiol Rev; 2018 Apr; 31(2):. PubMed ID: 29540434 [TBL] [Abstract][Full Text] [Related]
16. An overview of antimicrobial susceptibility patterns for gram-negative bacteria from the National Antimicrobial Resistance Surveillance Thailand (NARST) program from 2000 to 2005. Apisarnthanarak A; Buppunharun W; Tiengrim S; Sawanpanyalert P; Aswapokee N J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S91-4. PubMed ID: 21298849 [TBL] [Abstract][Full Text] [Related]
17. Evolution of β-lactams resistance in Gram-negative bacteria in Tunisia. Chouchani C; Marrakchi R; El Salabi A Crit Rev Microbiol; 2011 Aug; 37(3):167-77. PubMed ID: 21438848 [TBL] [Abstract][Full Text] [Related]
18. Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003. Wu CJ; Lee HC; Lee NY; Shih HI; Ko NY; Wang LR; Ko WC J Microbiol Immunol Infect; 2006 Apr; 39(2):135-43. PubMed ID: 16604246 [TBL] [Abstract][Full Text] [Related]
19. Predicting and preventing antimicrobial resistance utilizing pharmacodynamics: part II Gram-negative bacteria. Abdelraouf K; Linder KE; Nailor MD; Nicolau DP Expert Opin Drug Metab Toxicol; 2017 Jul; 13(7):705-714. PubMed ID: 28486001 [TBL] [Abstract][Full Text] [Related]
20. Resistant gram-negative bacilli: A neglected healthcare crisis? Lautenbach E; Polk RE Am J Health Syst Pharm; 2007 Dec; 64(23 Suppl 14):S3-21; quiz S22-4. PubMed ID: 18029939 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]